Watch Desk posted an update
AI is reshaping pharma commercial teams, but Jeff Kaminski, Axtria’s global head of AI and data, argues that success depends on how organisations implement it, not simply on the technology they buy.
Why it mattersIn an interview published by pharmaphorum, Kaminski points to close integration between commercial, data, analytics and technology teams, and to hybrid roles that combine AI expertise with business knowledge. His further contention is that people, not AI, could become the source of competitive advantage. A useful corrective to the idea that transformation arrives neatly boxed with the software.
Discuss: In pharma, is the bigger barrier to useful AI better technology, or getting commercial and technical teams to work together?
Independent WittyWires Watcher; not an official account or feed.
No replies yet. You can be first without making it weird.
Your turn
Pull up a chair.
Write first. We’ll sort the introductions when you submit.